-
Entity
-
Individual
-
Location
-
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
-
Summary
-
The estimated net worth of Andrew A. Hindman is at least $3.96M dollars as of November 22, 2022. Andrew A. Hindman is the SVP, CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $3.96M.